Status:
UNKNOWN
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma With Positive Circumstantial Resection Margin
Lead Sponsor:
Fudan University
Conditions:
Esophageal Squamous Cell Carcinoma
Positive Circumferential Resection Margin
Eligibility:
All Genders
18-18 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine the efficacy of adjuvant radiotherapy for esophageal squamous cell carcinoma with positive circumstantial resection margin.
Detailed Description
Although preoperative chemoradiation therapy followed by surgery is the most common approach for patients with resectable esophageal cancer, the considerable number of esophageal cancer patients recei...
Eligibility Criteria
Inclusion
- Patients with esophageal cancer who received R0 operations in Fudan University Shanghai Cancer Center and postoperative pathology: squamous cell cancer,positive Circumferential Resection Margin(CRM)+
- KPS≥70 before radiotherapy;
- Did not receive neoadjuvant or adjuvant treatment;
- No clear recurrent or metastatic lesions before radiotherapy;
- Intensity modulated radiation therapy(IMRT) is accepted;
- Regular follow-up.
Exclusion
- Exploratory thoracotomy or palliative surgery;
- No clear recurrent or metastatic sites;
- Recurrence or metastasis is not certain;
- death of no definite cause.
- Irregular follow-up;
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03273647
Start Date
December 1 2017
End Date
December 1 2024
Last Update
October 19 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.